Duck Cho

Title: **Innovative Breakthroughs by Inventor Duck Cho in Cancer Treatment**

Introduction

Duck Cho, an innovative inventor based in Seoul, South Korea, has made significant strides in the medical field, particularly in cancer treatment. With a strong focus on the development of biopharmaceuticals, Cho has secured one patent that highlights his work on enhancing the efficacy of cancer therapies.

Latest Patents

Duck Cho's notable patent is titled "NK cell-activating fusion protein, NK cell, and pharmaceutical composition including same." This invention revolves around a fusion protein designed for cancer treatment. The fusion protein comprises a fusion polypeptide that includes an antibody or a fragment of it that binds to a tumor-associated antigen, a linker, and an NK cell-inducing protein known as CXCL16. The key aspect of this innovation is its capacity to co-administer the fusion polypeptide alongside NK cells and other immunocyte therapeutic agents, which significantly enhances the influx of NK cells into cancerous tissues expressing specific antigens. This remarkable effect has the potential to improve the prevention and treatment of cancer.

Career Highlights

Duck Cho is affiliated with the Korea Research Institute of Bioscience and Biotechnology, a prominent institution dedicated to cutting-edge biomedical research. His role in this institute has allowed him to focus on advancements that could change the landscape of cancer therapies.

Collaborations

Duck Cho collaborates with talented professionals in his field, including Seok Ho Kim and Jaemin Lee. Together, they contribute to the advancement of biotechnological innovations that hold promise for improving cancer treatment options.

Conclusion

Duck Cho's commitment to innovating cancer treatment through his patent demonstrates his dedication to enhancing patient outcomes. As research continues to evolve, his contributions may pave the way for groundbreaking therapies, reinforcing the importance of innovation in the medical field.